Back to Search VC Home Page
Venture Capital Search Engine
search over 1,000 Venture Capital related sites
Keywords about VC:  

Odyssey Venture Partners - SAIL Fund

1.Frontenac Company - News   (77%):
Username Password Odyssey Investment Partners to Acquire Pro Mach, Inc., Packaging Systems Leader, from Frontenac Company November 2, 2004 Business Wire NEW YORK and ATLANTA - (BUSINESS WIRE) - Nov. 2, 2004 - Odyssey Investment Partners LLC and Pro Mach, Inc. ("Pro Mach" or the "Company") today anno...
2.CDC - About CDC - Global Communications Center   (72%):
Home | About CDC | Press Room | A-Z Index | Contact Us CDC en Español Search: About CDC: Global Communications Center View by Topic About Us Director Budget CDC Organization CDC Foundation Employment Events and Announcements Funding and Procurement Goals Mission Media Global Communications C...
3.Eos Private Equity Professionals   (66%):
Steven M. Friedman Steve is a General Partner of Eos. Prior to co-founding Eos in 1994, he was a General Partner at Odyssey Partners L.P., which he joined in 1983. Steve and Mr. Young were the partners responsible for Odyssey's private equity business. Before joining Odyssey, Steve was a vice presi...
4.Eos Private Equity Professionals   (66%):
Steven M. Friedman Steve is a General Partner of Eos. Prior to co-founding Eos in 1994, he was a General Partner at Odyssey Partners L.P., which he joined in 1983. Steve and Mr. Young were the partners responsible for Odyssey's private equity business. Before joining Odyssey, Steve was a vice presi...
5.Eos Private Equity Professionals   (66%):
Steven M. Friedman Steve is a General Partner of Eos. Prior to co-founding Eos in 1994, he was a General Partner at Odyssey Partners L.P., which he joined in 1983. Steve and Mr. Young were the partners responsible for Odyssey's private equity business. Before joining Odyssey, Steve was a vice presi...
6.Ridgewood   (62%):
ORYXE Energy International develops and commercializes patented and patent-pending energy products and environmental solutions based on breakthrough research in combustion technology. These products, when added to diesel, gasoline and other fossil fuels, alter the combusion dynamics and allow fuels ...
7.News About Commons Capital   (52%):
Commons Capital: Investing With A Conscience By Michelle Tsai, VentureWire, April 2, 2001 Most venture capital firms tout a bottom-line of good returns and business-building, but Commons Capital doesn't think that's enough. The Boston venture capital firm, which just announced its first close on $12...
8.CMEA Portfolio Companies   (52%):
Our portfolio companies are leaders in chemistry, information technology, clinical development, systems automation, biology, and much more. You may click on the categories to the left to learn more about CMEA's companies or individual portfolio company names on the right. All Portfolio Companies: A...
9.CrossBow Ventures News Room   (52%):
body { scrollbar-face-color:#E1E1F0; scrollbar-shadow-color:#505091; scrollbar-highlight-color:#E1E1F0; scrollbar-3dlight-color:#FFFFFF; scrollbar-darkshadow-color:#E1E1F0; scrollbar-track-color:#E1E1F0; scrollbar-arrow-color:#505091; } For Immediate Release March 25, 2004 Crossbow Ventures names Jo...
10.The Commons Capital Team   (52%):
Investment Advisory Committee: Bart Holaday is the former co-head of Private Markets and Managing Director of UBS Brinson, the Chicago investment management firm, where he oversaw the management of over $12 billion in private market investments. He was a member of UBS Brinson’s Investment Strat...
11.GreenHills Ventures   (51%):
Investors: Login | Businesses: Submit Plan GreenHills Ventures, LLC., combines extensive advisory experience with strategic initiatives. We focus on providing strong fundamentals to facilitate sound business execution. GreenHills Ventures, LLC., has developed an extensive network of Fortune 1000 co...
12.CrossBow Ventures Team Members   (50%):
As Managing Partner, John Benitz brings over 20 years of experience as private equity investor, investment banker and entrepreneur to Crossbow Ventures. Prior to joining Crossbow Ventures, John was Managing Partner of Odyssey Venture Group / Odyssey Capital, Hong Kong where he led the strategy, mana...
13.CMEA Ventures - High Technology Portfolio - CMEA IV   (50%):
Applied Wave Research, Inc. , (AWR) is a worldwide leader in high-frequency electronic design automation (EDA) software for wireless, high-speed wireline, and electro-optical applications. The company’s mission is to dramatically accelerate time-to-market and reduce product development costs f...
14.Gunderson Dettmer, Transactions and Clients   (50%):
Investors Represented In Investment Transactions Representative Investment Banking Clients Representative Private Technology Clients Representative Public Technology Clients Representative Medical Device/Life Science Clients Venture Funds For Which The Firm Serves As General Counsel Investors Repre...
15.CMEA Team - James Watson   (48%):
Jim Watson General Partner Jim Watson joined CMEA Ventures as General Partner in 2001, and is on the Board of Directors of Apriso, the world's premier provider of plant and warehouse automation solutions for the industrial sector; iSuppli Inc., a supply chain procurement firm; LiveOps, leading the ...
16.CMEA Ventures - Portfolio - CMEA VI   (43%):
Ambrx, Inc . is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics. Ambrx is based on a fundamental advance in protein biosynthesis that enables the company to genetically engineer proteins with new amino acid building blocks beyond the common twenty, enabling t...
17.CMEA Ventures - News Archive November 2004   (43%):
Kalypsys to Provide Los Alamos National Laboratory with Enabling Protein Expression and Purification Technologies http://biz.yahoo.com 11/30/04 - Yahoo/PRnewswire Ansell Seeks to ''Institutionalize Operational Excellence'' with Apriso Software; Event-driven FlexNet Ideal for Managing Worldwide Comp...
18.Flagship Ventures   (42%):
Flagship & Portfolio Company News Archives 2003 2002 Pervasis Therapeutics Closes $12 Million Series B Financing Cell Therapy Company Developing Next-Generation Combination Treatments Pervasis Therapeutics, Inc., a biotechnology company founded to develop the next generation of medical therapies tha...
19.Cypress Ventures   (41%):
About Us | Investment Profile | CIR Group Our Team | Advisory Board Contact: Elizabeth Robinson Volume Public Relations elizabeth@volumepr.com 720-529-4850 M7 Corporation Raises $9.5 Million in Funding Highland Capital Partners and Redpoint Ventures lead investment in leading edge J2EE enterprise s...
20.CMEA Ventures - High Technology Portfolio Companies   (40%):
Based on a revolutionary means of packaging custom circuits called NanoBlock ® ICs, Alien is using its high volume roll-to-roll process to produce low cost radio frequency tags, in which a small integrated wireless circuit is used to identify objects remotely. http://www.alientechnology.com App...

Page: 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20  

VC Directory: A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   Others